Comments
Loading...

Tenet Healthcare Analyst Ratings

THCNYSE
Logo brought to you by Benzinga Data
$162.83
-5.83-3.46%
At close: -
$162.83
0.000.00%
After Hours: 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$230.00
Lowest Price Target1
$81.00
Consensus Price Target1
$150.67

Tenet Healthcare Analyst Ratings and Price Targets | NYSE:THC | Benzinga

Tenet Healthcare Corp has a consensus price target of $150.67 based on the ratings of 27 analysts. The high is $230 issued by UBS on April 30, 2025. The low is $81 issued by JP Morgan on November 17, 2023. The 3 most-recent analyst ratings were released by B of A Securities, Truist Securities, and Goldman Sachs on May 14, 2025, May 12, 2025, and May 5, 2025, respectively. With an average price target of $174.67 between B of A Securities, Truist Securities, and Goldman Sachs, there's an implied 7.27% upside for Tenet Healthcare Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Jan
2
Feb
1
Mar
4
1
Apr
3
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B of A Securities
Truist Securities
Goldman Sachs
Morgan Stanley
Barclays

1calculated from analyst ratings

Analyst Ratings for Tenet Healthcare

Buy NowGet Alert
05/14/2025Buy Now10.54%B of A Securities
Kevin Fischbeck67%
$165 → $180MaintainsBuyGet Alert
05/12/2025Buy Now16.69%Truist Securities
David Macdonald67%
$175 → $190MaintainsBuyGet Alert
05/05/2025Buy Now-5.42%Goldman Sachs
Jamie Perse64%
$134 → $154MaintainsNeutralGet Alert
05/05/2025Buy Now7.47%Morgan Stanley
Craig Hettenbach59%
$165 → $175MaintainsOverweightGet Alert
04/30/2025Buy Now5.02%Barclays
Andrew Mok59%
$161 → $171MaintainsOverweightGet Alert
04/30/2025Buy Now16.07%RBC Capital
Ben Hendrix61%
$183 → $189MaintainsOutperformGet Alert
04/30/2025Buy Now41.25%UBS
A.J. Rice70%
$217 → $230MaintainsBuyGet Alert
04/15/2025Buy Now-15.86%Baird
Michael Ha47%
$153 → $137DowngradeOutperform → NeutralGet Alert
04/09/2025Buy Now1.33%Guggenheim
Jason Cassorla52%
→ $165Initiates → BuyGet Alert
03/26/2025Buy Now1.33%Morgan Stanley
Craig Hettenbach59%
→ $165Initiates → OverweightGet Alert
02/13/2025Buy Now8.7%Cantor Fitzgerald
Sarah James52%
$177 → $177ReiteratesOverweight → OverweightGet Alert
02/13/2025Buy Now-1.12%Barclays
Andrew Mok59%
$190 → $161MaintainsOverweightGet Alert
01/07/2025Buy Now13.62%Keybanc
Tim Rezvan51%
$200 → $185MaintainsOverweightGet Alert
01/06/2025Buy Now7.47%Truist Securities
David Macdonald67%
$190 → $175MaintainsBuyGet Alert
12/17/2024Buy Now7.47%JP Morgan
Benjamin Rossi66%
→ $175Assumes → OverweightGet Alert
12/16/2024Buy Now-14.02%Goldman Sachs
Jamie Perse64%
$196 → $140DowngradeBuy → NeutralGet Alert
11/25/2024Buy Now-7.88%Wells Fargo
Stephen Baxter54%
$205 → $150DowngradeOverweight → Equal-WeightGet Alert
11/22/2024Buy Now19.76%Raymond James
John Ransom76%
$195 → $195DowngradeStrong Buy → OutperformGet Alert
11/08/2024Buy Now16.69%Barclays
Andrew Mok59%
$171 → $190MaintainsOverweightGet Alert
11/06/2024Buy Now25.9%Wells Fargo
Stephen Baxter54%
$195 → $205MaintainsOverweightGet Alert
10/30/2024Buy Now8.7%Cantor Fitzgerald
Sarah James52%
$168 → $177MaintainsOverweightGet Alert
10/30/2024Buy Now20.37%Goldman Sachs
Jamie Perse64%
$173 → $196MaintainsBuyGet Alert
10/30/2024Buy Now12.39%RBC Capital
Ben Hendrix61%
$174 → $183MaintainsOutperformGet Alert
10/30/2024Buy Now16.69%Truist Securities
David Macdonald67%
$180 → $190ReiteratesBuy → BuyGet Alert
10/30/2024Buy Now33.27%UBS
A.J. Rice70%
$197 → $217MaintainsBuyGet Alert
10/22/2024Buy Now19.76%Wells Fargo
Stephen Baxter54%
$175 → $195MaintainsOverweightGet Alert
10/14/2024Buy Now10.54%Truist Securities
David Macdonald67%
$170 → $180MaintainsBuyGet Alert
10/11/2024Buy Now22.83%Keybanc
Matthew Gillmor66%
→ $200Initiates → OverweightGet Alert
10/04/2024Buy Now3.18%Cantor Fitzgerald
Sarah James52%
$168 → $168ReiteratesOverweight → OverweightGet Alert
10/01/2024Buy Now3.18%Cantor Fitzgerald
Sarah James52%
$168 → $168ReiteratesOverweight → OverweightGet Alert
08/20/2024Buy Now3.18%Cantor Fitzgerald
Sarah James52%
$168 → $168ReiteratesOverweight → OverweightGet Alert
08/19/2024Buy Now3.18%Cantor Fitzgerald
Sarah James52%
$168 → $168ReiteratesOverweight → OverweightGet Alert
08/14/2024Buy Now20.99%UBS
A.J. Rice70%
$180 → $197MaintainsBuyGet Alert
07/30/2024Buy Now6.25%Goldman Sachs
Jamie Perse64%
$156 → $173MaintainsBuyGet Alert
07/30/2024Buy Now7.47%Wells Fargo
Stephen Baxter54%
$145 → $175MaintainsOverweightGet Alert
07/29/2024Buy Now5.02%Barclays
Andrew Mok59%
$156 → $171MaintainsOverweightGet Alert
07/25/2024Buy Now5.02%Citigroup
Jason Cassorla52%
$139 → $171MaintainsBuyGet Alert
07/25/2024Buy Now7.47%Raymond James
John Ransom76%
$130 → $175MaintainsStrong BuyGet Alert
07/25/2024Buy Now4.4%Truist Securities
David Macdonald67%
$155 → $170ReiteratesBuy → BuyGet Alert
07/25/2024Buy Now3.18%Cantor Fitzgerald
Sarah James52%
$112 → $168MaintainsOverweightGet Alert
07/15/2024Buy Now-4.81%Truist Securities
David Macdonald67%
$130 → $155MaintainsBuyGet Alert
07/10/2024Buy Now-4.19%Barclays
Andrew Mok59%
$147 → $156MaintainsOverweightGet Alert
07/10/2024Buy Now-31.22%Cantor Fitzgerald
Sarah James52%
$112 → $112ReiteratesOverweight → OverweightGet Alert
07/09/2024Buy Now-31.22%Cantor Fitzgerald
Sarah James52%
$112 → $112ReiteratesOverweight → OverweightGet Alert
07/02/2024Buy Now-31.22%Cantor Fitzgerald
Sarah James52%
$112 → $112ReiteratesOverweight → OverweightGet Alert
06/28/2024Buy Now-4.81%Deutsche Bank
Pito Chickering68%
$150 → $155MaintainsBuyGet Alert
05/30/2024Buy Now-14.02%JP Morgan
Lisa Gill56%
$107 → $140MaintainsOverweightGet Alert
05/30/2024Buy Now-7.88%Deutsche Bank
Pito Chickering68%
$126 → $150MaintainsBuyGet Alert
05/30/2024Buy Now-6.04%Baird
Michael Ha47%
→ $153Initiates → OutperformGet Alert
05/02/2024Buy Now-9.72%Barclays
Andrew Mok59%
$113 → $147MaintainsOverweightGet Alert
05/01/2024Buy Now-25.08%Stephens & Co.
Scott Fidel69%
$95 → $122MaintainsEqual-WeightGet Alert
05/01/2024Buy Now-16.48%RBC Capital
Ben Hendrix61%
$109 → $136MaintainsOutperformGet Alert
05/01/2024Buy Now-7.88%UBS
A.J. Rice70%
$137 → $150MaintainsBuyGet Alert
05/01/2024Buy Now-20.16%Mizuho
Ann Hynes85%
$118 → $130ReiteratesBuy → BuyGet Alert
05/01/2024Buy Now-20.16%Truist Securities
David Macdonald67%
$120 → $130ReiteratesBuy → BuyGet Alert
04/12/2024Buy Now-22.62%Deutsche Bank
Pito Chickering68%
$100 → $126MaintainsBuyGet Alert
04/10/2024Buy Now-36.13%Cantor Fitzgerald
Sarah James52%
$104 → $104ReiteratesOverweight → OverweightGet Alert
03/28/2024Buy Now-29.37%Wells Fargo
Stephen Baxter54%
$105 → $115MaintainsOverweightGet Alert
03/27/2024Buy Now-25.08%Wolfe Research
Justin Lake31%
→ $122UpgradePeer Perform → OutperformGet Alert
03/11/2024Buy Now-32.44%Mizuho
Ann Hynes85%
$100 → $110MaintainsBuyGet Alert
03/06/2024Buy Now-30.6%Barclays
Andrew Mok59%
→ $113Initiates → OverweightGet Alert
03/05/2024Buy Now-36.13%Cantor Fitzgerald
Sarah James52%
$104 → $104ReiteratesOverweight → OverweightGet Alert
02/15/2024Buy Now-35.52%Wells Fargo
Stephen Baxter54%
$98 → $105MaintainsOverweightGet Alert
02/09/2024Buy Now-35.52%Truist Securities
David Macdonald67%
$92 → $105MaintainsBuyGet Alert
02/09/2024Buy Now-33.06%RBC Capital
Ben Hendrix61%
$97 → $109MaintainsOutperformGet Alert
02/09/2024Buy Now-38.59%Mizuho
Ann Hynes85%
$90 → $100MaintainsBuyGet Alert
02/09/2024Buy Now-36.13%Cantor Fitzgerald
Sarah James52%
$94 → $104MaintainsOverweightGet Alert
11/20/2023Buy Now-43.5%Truist Securities
David Macdonald67%
→ $92ReiteratesBuy → BuyGet Alert
11/17/2023Buy Now-50.25%JP Morgan
Calvin Sternick51%
$91 → $81MaintainsOverweightGet Alert
11/14/2023Buy Now-47.8%Jefferies
Brian Tanquilut46%
$95 → $85MaintainsBuyGet Alert
11/09/2023Buy Now-47.8%Goldman Sachs
Jamie Perse64%
$98 → $85MaintainsBuyGet Alert
11/02/2023Buy Now-42.27%UBS
Andrew Mok59%
$104 → $94MaintainsBuyGet Alert
11/01/2023Buy Now-44.73%Raymond James
John Ransom76%
$95 → $90MaintainsStrong BuyGet Alert
10/31/2023Buy Now-52.71%Mizuho
Ann Hynes85%
$94 → $77MaintainsBuyGet Alert
10/31/2023Buy Now-55.78%RBC Capital
Ben Hendrix61%
$87 → $72MaintainsOutperformGet Alert
10/20/2023Buy Now-56.4%Wells Fargo
Stephen Baxter54%
$83 → $71MaintainsOverweightGet Alert
09/14/2023Buy Now-42.27%Cantor Fitzgerald
Sarah James52%
$76 → $94MaintainsOverweightGet Alert
08/14/2023Buy Now-39.81%Goldman Sachs
Jamie Perse64%
$89 → $98MaintainsBuyGet Alert
08/02/2023Buy Now-39.81%Credit Suisse
A.J. Rice70%
$92 → $98MaintainsOutperformGet Alert
08/02/2023Buy Now-41.66%Raymond James
John Ransom76%
$85 → $95MaintainsStrong BuyGet Alert
08/01/2023Buy Now-36.13%UBS
Andrew Mok59%
$95 → $104MaintainsBuyGet Alert
08/01/2023Buy Now-46.57%RBC Capital
Ben Hendrix61%
$84 → $87MaintainsOutperformGet Alert
08/01/2023Buy Now-45.34%Stephens & Co.
Scott Fidel69%
$87 → $89MaintainsEqual-WeightGet Alert
08/01/2023Buy Now-44.73%Citigroup
Jason Cassorla52%
$83 → $90MaintainsBuyGet Alert
07/11/2023Buy Now-42.27%Mizuho
Ann Hynes85%
$81 → $94MaintainsBuyGet Alert
06/20/2023Buy Now-43.5%Truist Securities
Ryan MacDonald62%
$84 → $92MaintainsBuyGet Alert
06/14/2023Buy Now-41.66%Jefferies
Brian Tanquilut46%
→ $95Reiterates → BuyGet Alert
05/16/2023Buy Now-50.25%Mizuho
Ann Hynes85%
$78 → $81MaintainsBuyGet Alert
04/26/2023Buy Now-50.25%Deutsche Bank
Pito Chickering68%
$65 → $81MaintainsBuyGet Alert
04/26/2023Buy Now-48.41%Truist Securities
Ryan MacDonald62%
$74 → $84MaintainsBuyGet Alert
04/26/2023Buy Now-48.41%RBC Capital
Ben Hendrix61%
$73 → $84MaintainsOutperformerGet Alert
04/26/2023Buy Now-47.8%Raymond James
John Ransom76%
$72 → $85MaintainsStrong BuyGet Alert
04/26/2023Buy Now-52.71%Stephens & Co.
Scott Fidel69%
$64 → $77MaintainsEqual-WeightGet Alert
04/26/2023Buy Now-35.52%Barclays
Steve Valiquette52%
$70 → $105MaintainsOverweightGet Alert
04/21/2023Buy Now-55.17%Cantor Fitzgerald
Sarah James52%
→ $73Initiates → OverweightGet Alert
04/19/2023Buy Now-55.78%JP Morgan
Calvin Sternick51%
→ $72Initiates → OverweightGet Alert
02/22/2023Buy Now-60.7%Stephens & Co.
Scott Fidel69%
$60 → $64MaintainsEqual-WeightGet Alert
02/17/2023Buy Now-58.24%Wells Fargo
Stephen Baxter54%
$59 → $68MaintainsOverweightGet Alert
02/17/2023Buy Now-52.1%Mizuho
Ann Hynes85%
$60 → $78MaintainsBuyGet Alert
02/14/2023Buy Now-52.1%UBS
Andrew Mok59%
$47 → $78MaintainsBuyGet Alert

FAQ

Q

What is the target price for Tenet Healthcare (THC) stock?

A

The latest price target for Tenet Healthcare (NYSE:THC) was reported by B of A Securities on May 14, 2025. The analyst firm set a price target for $180.00 expecting THC to rise to within 12 months (a possible 10.54% upside). 49 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Tenet Healthcare (THC)?

A

The latest analyst rating for Tenet Healthcare (NYSE:THC) was provided by B of A Securities, and Tenet Healthcare maintained their buy rating.

Q

When was the last upgrade for Tenet Healthcare (THC)?

A

The last upgrade for Tenet Healthcare Corp happened on March 27, 2024 when Wolfe Research raised their price target to $122. Wolfe Research previously had a peer perform for Tenet Healthcare Corp.

Q

When was the last downgrade for Tenet Healthcare (THC)?

A

The last downgrade for Tenet Healthcare Corp happened on April 15, 2025 when Baird changed their price target from $153 to $137 for Tenet Healthcare Corp.

Q

When is the next analyst rating going to be posted or updated for Tenet Healthcare (THC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenet Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenet Healthcare was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.

Q

Is the Analyst Rating Tenet Healthcare (THC) correct?

A

While ratings are subjective and will change, the latest Tenet Healthcare (THC) rating was a maintained with a price target of $165.00 to $180.00. The current price Tenet Healthcare (THC) is trading at is $162.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch